NovoCure (NVCR) Stock Price
$22.09 0%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
2 -
Technical
5
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on NovoCure, AI stock picks, stock alerts and much more.
NVCR AI Stock Analysis
AI stock analysis for NVCR is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like NovoCure (NVCR) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
NovoCure (NVCR) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of NovoCure (NVCR), currently trading at $22.09, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About NVCR
-
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China.
-
Symbol
NVCR
-
Market
NASDAQ
-
Industry
Medical - Instruments & Supplies
-
Market Cap
2.4B
Similar Stocks
 |
Dentsply XRAY |
$18.75 1.1% |
4 |
 |
Intuitive Surgical ISRG |
$591.8 2.4% |
8 |
 |
LeMaitre Vascular LMAT |
$99.54 1.4% |
8 |
 |
ICU Medical ICUI |
$157.3 3.6% |
6 |
 |
Hologic HOLX |
$64.49 0.3% |
6 |
News
NVCR Alternative Data
Web Traffic
NovoCure receives an estimated 67563 monthly visitors to novocure.com.
-
Web Traffic
67563
-
Change from Previous Month
61.1%
-
3 Month Change
106.7%
-
YoY Change
106.7%
News Mentions
NovoCure was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
NovoCure has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
Twitter Followers
NovoCure has 2,724 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.2% over the last month.
-
Twitter Followers
2724
-
Daily Change
0.1%
-
1 Month Change
0.2%
-
3 Month Change
0.4%
-
YoY Change
0.4%
LinkedIn Followers
55,368 are following NovoCure on LinkedIn, up by 2% over the last month.
-
LinkedIn Followers
55368
-
Daily Change
0.1%
-
1 Month Change
2%
-
3 Month Change
6.5%
Job Postings
NovoCure currenly has an estimated 56 open job postings, up by 19.1% over the last month.
-
Job Postings
56
-
Daily Change
1.8%
-
1 Month Change
19.1%
-
3 Month Change
9.8%
-
YoY Change
9.8%
LinkedIn Employees
According to LinkedIn, NovoCure has 1,395 employees, up by 0.4% over the last month.
-
LinkedIn Employees
1395
-
Daily Change
0%
-
1 Month Change
0.4%
-
3 Month Change
1.1%
-
YoY Change
1.1%
Business Outlook
-
Business Outlook
37
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
NVCR Financials
NVCR Key Metrics
-
Total Revenue
$155.1M
-
Net Income
-$30.6M
-
Earnings per Share
-$0.28
-
Free cash flow
-$307K
-
EBITDA
-$29.6M
-
EBITDA Ratio
-0.19107
-
Total Assets
$1.2B
NVCR 2-year Revenue & Income
NVCR 2-year Free Cash Flow
NVCR Technicals
NVCR SMA
NVCR RSI
FAQ
What's the current price of NovoCure (NVCR) Stock?
The price of an NovoCure (NVCR) share is $22.09.
What's the market cap of NovoCure?
The current market cap of NovoCure is 2.4B.
Should I buy or sell NVCR?
NovoCure shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, NovoCure is better viewed as a hold or accumulate position while waiting for further developments.
Is NovoCure a good investment?
The current analysis of NovoCure's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in NovoCure's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy NovoCure (NVCR) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for NovoCure stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to NovoCure (NVCR) that investors often compare it to?
NovoCure (NVCR) is often compared to similar stocks such as Dentsply, Intuitive Surgical, LeMaitre Vascular, ICU Medical and Hologic.
What is the forecast for NovoCure's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast NovoCure's stock price to be around $21.94 in 2026. Starting from the current price of $22.09, this represents a 0.7% change in price, indicating a neutral outlook for the stock.
How to buy NovoCure (NVCR) Stock?
NovoCure stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy NovoCure shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.